Baseline Pharmacotherapy Provides Prognostic Insight in Clinical High-Risk Psychosis

This study highlights the prognostic value of baseline pharmacological treatment in individuals at clinical high-risk for psychosis (CHR-P). It emphasizes that medication exposure at the onset of CHR-P, despite potential confounding factors, carries important information about prior clinical status and symptom burden, aiding early intervention strategies.

Originally published by gnews